9.77
price down icon0.31%   -0.03
pre-market  시장 영업 전:  9.83   0.06   +0.61%
loading

Lexeo Therapeutics Inc (LXEO) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
기간 3개월 3개월 3개월 3개월 3개월
Revenues
-
- - - -
Operating Expenses
9.22%
30.69
33.80 27.38 31.54 23.55
Depreciation and Amortization
3.33%
0.062
0.06 0.075 0.083 0.077
Operating Income/Loss
9.22%
-30.69
-33.80 -27.38 -31.54 -23.55
Nonoperating Income/Loss
299.04%
4.585
1.149 1.458 2.054 2.312
Income/Loss From Continuing Operations Before Tax
20.07%
-26.10
-32.66 -25.92 -29.49 -21.24
Income/Loss From Continuing Operations After Tax
20.07%
-26.10
-32.66 -25.92 -29.49 -21.24
Net Income/Loss
20.07%
-26.10
-32.66 -25.92 -29.49 -21.24
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
31.59%
43.57
33.11 0.4327 33.06 33.00
Diluted Average Shares
31.59%
43.57
33.11 0.4327 33.06 33.00
Basic Earnings Per Share
39.39%
-0.60
-0.99 -0.78 -0.89 -0.64
Diluted Earnings Per Share
39.39%
-0.60
-0.99 -0.78 -0.89 -0.64
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$38.39
price down icon 1.08%
$95.41
price down icon 0.72%
$31.31
price down icon 3.07%
$94.81
price down icon 1.24%
biotechnology ONC
$319.06
price down icon 0.55%
$197.01
price up icon 0.91%
자본화:     |  볼륨(24시간):